Artificial Intelligence

Promising trial data for onvansertib offers new hope for colorectal cancer patients, yet leadership changes and financial hurdles cloud the path forward.

Navitas Semiconductor accepts short-term losses for a future in AI data centers and energy, signaling a major shift in the power electronics landscape.

Archrock crushes profit estimates and hikes its dividend, signaling strong confidence as it positions to power the soaring energy demands of LNG and AI.

All eyes are on Micron's March 18 report as a key test of the AI-fueled memory market recovery and the firm's strategic pivot to high-value tech.

onsemi will detail its long-term financial and innovation roadmap, focusing on capitalizing on AI, EV, and industrial megatrends amid fierce competition.

Following strong Q4 earnings, Datadog will detail its AI and cloud strategy at a major conference, with investors and tech leaders watching closely.

After a major trial miss sent its stock tumbling, GRAIL will face investors to pitch its vision for the future of early cancer detection technology.

Latin American giant MercadoLibre posts record revenue for 2025 but misses profit estimates, sending shares lower as it invests heavily in future growth.

LexisNexis integrates Anthropic's powerful Legal Plugin, escalating the AI arms race and promising a new era of automated, verifiable legal work.

Sirion's recognition by The Hackett Group validates its AI-native approach, signaling a major shift in enterprise procurement and contract management.

A Senate hearing highlights a growing national trend: using advanced tech to stop fraud and ensure billions in child care funds reach the families who need them.

A new national research initiative will explore how AI can help universities scale online programs without sacrificing quality, focusing on human-AI collaboration.

New research shows employees bypass learning platforms for managers. Go1's new tool empowers managers to fund real-world development beyond eLearning.

Nabsys's electronic genome mapping reveals how rogue genetic elements damage our DNA, opening new frontiers in understanding cancer and neurodegeneration.

A new solar-powered detection trailer offers a flexible, data-driven weapon against a rising tide of wrong-way crashes on America’s highways.

A newly identified blood biomarker for the drug masitinib could revolutionize how doctors treat ALS, progressive MS, and Alzheimer's disease.

Groundbreaking research shows AI's information diet is dangerously imbalanced, creating an unseen force that could manipulate public opinion and erode democracy.

A new security framework from Crittora aims to eliminate a core AI vulnerability, making autonomous agents enterprise-ready and setting a new trust standard.

A massive new study finds ECGs save young lives, questioning UK policy as 12 die weekly from hidden heart conditions. Is repeat screening the answer?

The global testing giant's latest move deepens its U.S. consulting services, signaling a major strategic shift in a competitive North American market.